The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of next-generation sequencing (NGS) to integrate identified genomic alterations (GA) into cancer treatment decisions in gastrointestinal (GI) tumors.
Madappa N. Kundranda
No relevant relationships to disclose
Donald Peter Braun
No relevant relationships to disclose
Kim Kramer
No relevant relationships to disclose
Edgar Donald Staren
No relevant relationships to disclose
Brad Tan
No relevant relationships to disclose
Bruce G. Gershenhorn
No relevant relationships to disclose
Eiko Klimant
No relevant relationships to disclose
Brion Vincent Randolph
No relevant relationships to disclose
Maurie Markman
No relevant relationships to disclose